13/04/2015 - 21:00 In a population of patients with hematologic malignancies who refuse blood product transfusions, high-dose chemotherapy (HDC) followed by autologous s... More » Visit websiteField of Interest: OncologyCategories: CME-candidateONCR || NewsONCR || Lymphoma and Plasma Cell DisordersIMN || NewsIMN || OncologyHOSP || NewsFPN || NewsNews Feed: Internal Medicine News - Oncology